RADIOIMMUNODETECTION OF CANCER USING ANTIBODIES TO α‐FETOPROTEIN AND CARCINOEMBRYONIC ANTIGEN
- 16 December 1983
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 417 (1) , 270-276
- https://doi.org/10.1111/j.1749-6632.1983.tb32870.x
Abstract
This study reports the use of radiolabeled antibody to AFP and CEA for the detection and localization of AFP- or CEA-producing tumors. Thirty-one patients received 131I-labeled anti-AFP or anti-CEA antibodies. Photoscans were taken at 24 and 48 hours after injection of radioantibodies. In three of six patients with CEA-producing tumors, radioimmunodetection with anti-CEA antibody showed positive scans. In AFP-producing tumors, 7 of 15 patients had positive findings on immunoscintigraphy using polyclonal anti-AFP antibody, and two of nine patients had positive findings when monoclonal antibodies were used. Analysis of radioantibody in the blood after injection showed both complex and free antibody with immunoreactivity in the circulation, and smaller complexes were seen to form after administration of monoclonal antibodies.Keywords
This publication has 3 references indexed in Scilit:
- Clinical studies on the radioimmunodetection of tumors containing alpha-fetoproteinCancer, 1980
- Radioimmunodetection of colorectal cancerCancer, 1980
- Use of Radiolabeled Antibodies to Carcinoembryonic Antigen for the Detection and Localization of Diverse Cancers by External PhotoscanningNew England Journal of Medicine, 1978